Search results
Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago
Benzinga via AOL· 13 hours agoThe FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., partially due to...
FDA recinds order blocking Juul’s e-cigarette marketing
Consumer Affairs· 14 hours agoThe U.S. Food and Drug Administration (FDA) has done an about face, recinding its marketing denial...
FDA reverses ban on Juul vape products, which remain on shelves
Washington Post· 15 hours agoThe decision will not immediately affect consumers — Juul products have remained on store shelves as...
Some Breather For E-Cigarette Maker Juul As FDA Reconsiders Marketing Denials Issued Two Years Ago
Benzinga· 13 hours agoThe FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., partially due to...
FDA reverses marketing ban on JUUL vaping products
New York Daily News· 14 hours agoThe reversal comes nearly two years after the federal health agency ordered JUUL to stop selling products — including its vaping devices as well as its...
US FDA rescinds market denial order for Juul products
Reuters via AOL· 18 hours agoThe latest move comes a few months after Juul sought an FDA authorization for new menthol-flavored...
FDA rolls back Juul marketing ban, reopening possibility of authorization
WLTX-TV Columbia· 11 hours agoThe marketing denial orders were effectively paused by the agency not long after they were issued,...
FDA reverses its ban on Juul vaping products
Scripps News via AOL· 11 hours agoThe U.S. Food and Drug Administration has reversed its ban on JUUL products, potentially opening the door for the brand to get its e-cigarettes and vapes...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 19 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
FDA rescinds marketing ban on Juul vaping products
Local 3 News Chattanooga· 13 hours agoJuul said Thursday its products will remain on the market during scientific review. On Thursday, the FDA said court decisions since then “establish new case law and inform ...
